Posts Tagged ‘phentermine-topiramate’

Qsymia Adds to the Possibilities for Teens with Obesity

May 2, 2022 — At the Pediatric Endocrine Society annual meeting this weekend came some good news. Pediatric obesity care providers may soon have one more option for treating teens with obesity. In a well-controlled study of Qsymia for treating obesity in teens, Aaron Kelly reported impressive results. He and his colleagues tested two doses – a mid-range and […]

A Beauty Contest for Obesity Meds in JAMA

June 17, 2016 — A new study published this week in JAMA provides useful perspective on the safety and efficacy of the newer obesity meds now available for managing the chronic disease of obesity. Rohan Khera and colleagues integrated the results for 29,018 patients in 28 published clinical trials and concluded: Among overweight or obese adults, orlistat [Alli, Xenical], […]

New Data Shifting Attitudes on Obesity Treatment

July 2, 2015 — The response to new data on obesity treatment — published today in the New England Journal of Medicine — gives us some flicker of hope that attitudes about obesity treatment are shifting. The publication is the 56-week pivotal safety and efficacy study of liraglutide for treating obesity. Xavier Pi-Sunyer and colleagues found that most (63%) […]

Slim Pickings or Superficial Analysis?

August 7, 2014 — A superficial analysis of new obesity treatment options in JAMA Internal Medicine has prompted some strong pushback from two of the top organizations devoted to obesity. Leaders of the Obesity Society (TOS) and the Obesity Action Coalition (OAC) this week published rebuttals in the journal to the earlier publication on these new obesity drugs. In the original publication, Steven Woloshin and Lisa […]